BioNTech: No need to adapt coronavirus vaccine to variants yet

The effectiveness of vaccines got here to the fore at a time when circumstances from the delta variant had been on the rise worldwide.

Germany-based biotechnology firm BioNTech made an announcement on the topic.


Within the assertion, “There isn’t a need yet to adapt the BioNTech-Pfizer vaccine for coronavirus variants.” it was mentioned.

Uğur Şahin, Chairman of BioNTech’s Board of Administrators, said that the coronavirus vaccine produced by his firms is efficient in opposition to variants, “There’s at present no proof that adapting our vaccine to current variants is important.” he had spoken.

#BioNTech #adapt #coronavirus #vaccine #variants

Dikkat: Sitemiz herkese açık bir platform olduğundan, çox fazla kişi paylaşım yapmaktadır. Sitenizden izinsiz paylaşım yapılması durumunda iletişim bölümünden bildirmeniz yeterlidir.
You May Also Like:  The number of corona cases in the USA has risen to over 100 thousand again

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Uzayda film çeken yönetmen, gözünü Mars ve Ay’a dikti!

A third dose may be required for the vaccine